McMillion Capital Management’s AbbVie ABBV Stock Holding History

McMillion Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$7.41K	Buy	+55	New	+$8.06K	0.01%	156
2022 Q4	–	Sell	-55	Closed	-$7K	–	76
2022 Q3	$7K	Hold	55	–	–	0.01%	165
2022 Q2	$8K	Buy	+55	New	+$8.4K	0.01%	174
2021 Q1	–	Sell	-55	Closed	-$6K	–	84
2020 Q4	$6K	Buy	+55	New	+$5.29K	﹤0.01%	231
2020 Q2	–	Sell	-55	Closed	-$4K	–	70
2020 Q1	$4K	Hold	55	–	–	﹤0.01%	240
2019 Q4	$5K	Hold	55	–	–	﹤0.01%	232
2019 Q3	$4K	Hold	55	–	–	﹤0.01%	232
2019 Q2	$4K	Buy	+55	New	+$4.32K	﹤0.01%	241
2014 Q3	–	Sell	-26,461	Closed	-$1.49M	–	69
2014 Q2	$1.49M	Buy	26,461 +208	+0.8%	+$10.9K	0.86%	47
2014 Q1	$1.35M	Sell	26,253 -65	-0.2%	-$3.29K	0.82%	47
2013 Q4	$1.39M	Sell	26,318 -855	-3%	-$42K	0.85%	48
2013 Q3	$1.22M	Sell	27,173 -1,400	-5%	-$62.1K	0.87%	41
2013 Q2	$1.18M	Buy	+28,573	New	+$1.25M	0.87%	39

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

McMillion Capital Management's ABBV Position: Q2 2023 in Review

McMillion Capital Management opened a new position in AbbVie (ABBV) in Q2 2023: 55 shares worth $7.41K. The stake represents 0.01% of the portfolio and ranks #156 among its holdings. This is a return to the name: McMillion Capital Management previously reported a position in ABBV as recently as Q3 2022.

McMillion Capital Management first reported a position in ABBV in Q2 2013 and has held it in 13 quarters since. The position peaked at $1.49M in Q2 2014. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

McMillion Capital Management held 55 shares of AbbVie worth $7.41K as of Q2 2023.
AbbVie was a new McMillion Capital Management position in Q2 2023.
AbbVie made up 0.01% of McMillion Capital Management's portfolio in Q2 2023, its #156 holding.
McMillion Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 13 quarters since.
McMillion Capital Management's AbbVie position peaked at $1.49M in Q2 2014.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.